Detalles de la búsqueda
1.
Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT).
J Urol
; 210(2): 299-311, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37126069
2.
Voxel-based dosimetry predicting treatment response and related toxicity in HCC patients treated with resin-based Y90 radioembolization: a prospective, single-arm study.
Eur J Nucl Med Mol Imaging
; 50(6): 1743-1752, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36650357
3.
18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial.
Lancet
; 397(10288): 1895-1904, 2021 05 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33971152
4.
Accuracy and Safety of Scout Dose Resin Yttrium-90 Microspheres for Radioembolization Therapy Treatment Planning: A Prospective Single-Arm Clinical Trial.
J Vasc Interv Radiol
; 33(12): 1578-1587.e5, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36075560
5.
82Rubidium chloride positron emission tomography discrimination of recurrent intracranial malignancy from radiation necrosis.
Q J Nucl Med Mol Imaging
; 66(1): 74-81, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31820882
6.
Tumor-to-Normal Ratio Relationship between Planning Technetium-99 Macroaggregated Albumin and Posttherapy Yttrium-90 Bremsstrahlung SPECT/CT.
J Vasc Interv Radiol
; 32(5): 752-760, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33642158
7.
Role of 18F-Fluciclovine and Prostate-Specific Membrane Antigen PET/CT in Guiding Management of Oligometastatic Prostate Cancer: AJR Expert Panel Narrative Review.
AJR Am J Roentgenol
; 216(4): 851-859, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33206564
8.
[18F]Fluciclovine Positron Emission Tomography/Computerized Tomography for Preoperative Staging in Patients with Intermediate to High Risk Primary Prostate Cancer.
J Urol
; 204(4): 734-740, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32347780
9.
[18F]Fluciclovine PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging-version 1.0.
Eur J Nucl Med Mol Imaging
; 47(3): 579-591, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31822959
10.
The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial.
J Urol
; 201(2): 322-331, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30179618
11.
Feasibility and Initial Results: Fluciclovine Positron Emission Tomography/Ultrasound Fusion Targeted Biopsy of Recurrent Prostate Cancer.
J Urol
; 202(2): 413-421, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30817240
12.
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0.
Eur J Nucl Med Mol Imaging
; 46(3): 540-557, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30519867
13.
Fluorine-18-Labeled Fluciclovine PET/CT in Clinical Practice: Factors Affecting the Rate of Detection of Recurrent Prostate Cancer.
AJR Am J Roentgenol
; 213(4): 851-858, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31216198
14.
Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy-treated macaques.
Nat Methods
; 12(5): 427-32, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25751144
15.
Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). Reply.
J Urol
; 210(3): 411-412, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37350185
16.
Reply by Authors.
J Urol
; 210(2): 310-311, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37416959
17.
Current Clinical Practice Patterns of Self-Identified Nuclear Medicine Specialists.
AJR Am J Roentgenol
; 211(5): 978-985, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30085843
18.
Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (18F) Positron Emission Tomography/Computerized Tomography Imaging in the Staging of Biochemically Recurrent Prostate Cancer.
J Urol
; 197(3 Pt 1): 676-683, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27746282
19.
PET Molecular Imaging-Directed Biopsy: A Review.
AJR Am J Roentgenol
; 209(2): 255-269, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28504563
20.
Fasting Enhances the Contrast of Bone Metastatic Lesions in 18F-Fluciclovine-PET: Preclinical Study Using a Rat Model of Mixed Osteolytic/Osteoblastic Bone Metastases.
Int J Mol Sci
; 18(5)2017 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-28468238